ау при до 10%, и суицидни намерения при до 1% от пациентите, приемащи римонабант (вж. точка 4. 8).
or Depressive disorders or mood alterations with depressive symptoms have been reported in up to 10%, and suicidal ideation in up to 1%, of patients receiving rimonabant (see section 4.8).